Maynard Um
-
-
-
-
-
-
-
Theralase(R) Grants Stock Options
-
-
-
-
-
-
-
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
-
-
-
-
-
-
-
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
-
-
-
-
-
-
-
Theralase raises $1.3M in private placement for cancer study
-
-
-
-
-
-
-
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
-
-
-
-
-
-
-
Theralase Completes Annual General and Special Meeting
-
-
-
-
-
-
-
Theralase Discovers New Mechanism of Action of Lead Drug
-
468,809 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


